111 Inc (YI) - Total Assets
Based on the latest financial reports, 111 Inc (YI) holds total assets worth $2.20 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore YI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
111 Inc - Total Assets Trend (2016–2025)
This chart illustrates how 111 Inc's total assets have evolved over time, based on quarterly financial data. See 111 Inc book value and equity for net asset value and shareholders' equity analysis.
111 Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
111 Inc's total assets of $2.20 Billion consist of 96.6% current assets and 3.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.5% |
| Accounts Receivable | $318.51 Million | 14.5% |
| Inventory | $999.10 Million | 45.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $868.55K | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how 111 Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see YI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 111 Inc's current assets represent 96.6% of total assets in 2025, an increase from 95.7% in 2016.
- Cash Position: Cash and equivalents constituted 25.5% of total assets in 2025, down from 39.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 45.4% of total assets.
111 Inc Competitors by Total Assets
Key competitors of 111 Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
China National Accord Medicines Corp Ltd
SHE:000028
|
China | CN¥50.56 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
111 Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.09 | 1.14 | 1.43 |
| Quick Ratio | 0.58 | 0.53 | 0.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $171.29 Million | $310.51 Million | $883.70 Million |
111 Inc - Advanced Valuation Insights
This section examines the relationship between 111 Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.66 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -21.0% |
| Total Assets | $2.20 Billion |
| Market Capitalization | $20.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values 111 Inc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: 111 Inc's assets decreased by 21.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for 111 Inc (2016–2025)
The table below shows the annual total assets of 111 Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.20 Billion | -21.02% |
| 2024-12-31 | $2.79 Billion | -9.75% |
| 2023-12-31 | $3.09 Billion | -11.08% |
| 2022-12-31 | $3.47 Billion | +10.43% |
| 2021-12-31 | $3.15 Billion | +3.94% |
| 2020-12-31 | $3.03 Billion | +87.95% |
| 2019-12-31 | $1.61 Billion | +4.13% |
| 2018-12-31 | $1.55 Billion | +102.57% |
| 2017-12-31 | $763.38 Million | -18.93% |
| 2016-12-31 | $941.61 Million | -- |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more